drugset / Trial / NCT04157868

Early rhBNP on Myocardial Work in Patients With STEMI

NCT04157868 ↗

Phase 4 Unknown 200 enrolled RenJi Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study intends to evaluate the efficacy of early rhBNP on myocardial work in patients with anterior ST-segment elevation myocardial infarction after percutaneous coronary intervention

Timeline

Start
2019-11-30
Primary completion
2022-09-30
Completion
2022-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject rhBNP Peptide 0.0075 ug/kg Other
Subject rhBNP Peptide 0.01 ug/kg Other